(OTCQB) – Business Wire
-
Devonian Health Group Receives a Notice of Allowance for Issuance of a U.S. Patent On a Method of Treatment of Inflammatory Bowel Disease.
-
Devonian Health Group Announces Presentation of Thykamine™ Efficacy Results in Atopic Dermatitis at the World Congress of Dermatology and Provides Thykamine™ Clinical Development Program Update.
-
Devonian Health Group Announces the Appointment of New Board Members and Grant of Stock Options
-
Graphex Technologies and Northern Graphite Join Forces on Large-Scale Graphite Processing Facility Site Evaluations in Baie-Comeau
-
Devonian Announces Adoption of Restricted Share Unit Plan
-
GA Telesis Unveils Aero Inventory Management (AIM) Program with Launch Customer Global Crossing Airlines
-
Acerus to Report 2019 Financial Results
-
Acerus to Report Third Quarter 2019 Financial Results and Host Investor Call
Back to OTCQB Stock Lookup